Zydus Cadila has launched the most effective Remdesivir used to treat corona.
Pharma company Zydus Cadila has launched the cheapest generic version of Gilead Sciences' antiviral drug Ramdasivir. According to news agency Reuters, Zydus has priced it at 2,800 ($ 37.44) per 100 mg bottle.
During clinical trials in hospitals around the world, it was found that the duration of Remdesivir corona symptoms could be reduced from 15 days to 11 days.
This has also increased the demand for Remdesivir. However, experts warn that this is not an effective treatment.
But in the absence of any medicine, doctors are prescribing this medicine for corona patients in India. This has led to increased demand in Delhi and other cities in India.
Read Also::
Gilead Sciences in America -
Remadesevir was originally developed by America-based Gilead Sciences for Ebola treatment. It has now allowed India's Cipla, Jubilant Life, Hetero Drugs, and Mylon to manufacture the drug in India.
Pharma company Zydus Cadila has begun human testing of its potential Covid-19 vaccine ZyCoV-D. The company said in a piece of regulatory information that in the first phase it would register 1000 people in different parts of the country for this.
The company said the adaptive phase I / II human clinical trial of ZyCoV-D has begun with the first human dose. In this multidisciplinary study, vaccine safety, tolerability, and immunity will be assessed.
No comments:
Post a Comment